Results 191 to 200 of about 102,954 (248)
Clinical efficacy and mechanism of <i>Bletilla striata</i> and Chinese herbal compounds in treatment of peptic ulcer. [PDF]
Sun YT, Zhou F, Zheng HX, Xiao JD.
europepmc +1 more source
Trends and disparities in peptic ulcer disease-related mortality in the United States from 1999 to 2020: A cross-sectional study. [PDF]
Babar M +11 more
europepmc +1 more source
Nonsteroidal Anti-Inflammatory Drug-Induced Peptic Ulcer Disease. [PDF]
Ko KA, Lee DK.
europepmc +1 more source
Epidemiology and Outcomes of Peptic Ulcer Perforation: An Analytical Cross-Sectional Study From a Tertiary Care Hospital in India. [PDF]
Murmu U +9 more
europepmc +1 more source
Comparing the Efficacy and Safety of Fexuprazan and Lansoprazole for the Prevention of Nonsteroidal Anti-inflammatory Drug-Induced Peptic Ulcer. [PDF]
Hong S +28 more
europepmc +1 more source
Sarcopenia in the era of aging populations: its clinical implications for peptic ulcer bleeding. [PDF]
Hisada H, Tsuji Y, Fujishiro M.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Lancet, 2002
The discovery of Helicobacter pylori has greatly changed our approach to peptic ulcer disease. Bacterial, host, and environmental factors all have a role in peptic-ulcer disease. Although the prevalence of uncomplicated peptic ulcers is falling, hospital admissions for ulcer complications associated with non-steroidal anti-inflammatory drugs (NSAIDs ...
Leung, WK, Chan, FKL
openaire +5 more sources
The discovery of Helicobacter pylori has greatly changed our approach to peptic ulcer disease. Bacterial, host, and environmental factors all have a role in peptic-ulcer disease. Although the prevalence of uncomplicated peptic ulcers is falling, hospital admissions for ulcer complications associated with non-steroidal anti-inflammatory drugs (NSAIDs ...
Leung, WK, Chan, FKL
openaire +5 more sources
The Lancet, 2017
The rapidly declining prevalence of Helicobacter pylori infection and widespread use of potent anti-secretory drugs means peptic ulcer disease has become substantially less prevalent than it was two decades ago. Management has, however, become more challenging than ever because of the threat of increasing antimicrobial resistance worldwide and ...
Angel, Lanas, Francis K L, Chan
openaire +4 more sources
The rapidly declining prevalence of Helicobacter pylori infection and widespread use of potent anti-secretory drugs means peptic ulcer disease has become substantially less prevalent than it was two decades ago. Management has, however, become more challenging than ever because of the threat of increasing antimicrobial resistance worldwide and ...
Angel, Lanas, Francis K L, Chan
openaire +4 more sources
Medicina Clínica (English Edition), 2023
Peptic ulcer disease is a frequent pathology; although the incidence has decreased in recent years, it continues to be an important cause of morbidity and mortality associated with high healthcare costs. The most important risk factors are Helicobacter pylori(H. pylori) infection and the use of non-steroidal anti-inflammatory drugs.
Isabel, Laucirica +2 more
openaire +2 more sources
Peptic ulcer disease is a frequent pathology; although the incidence has decreased in recent years, it continues to be an important cause of morbidity and mortality associated with high healthcare costs. The most important risk factors are Helicobacter pylori(H. pylori) infection and the use of non-steroidal anti-inflammatory drugs.
Isabel, Laucirica +2 more
openaire +2 more sources

